US Stock MarketDetailed Quotes

XOMA XOMA Corp

Watchlist

24.710
-0.880-3.44%

Close May 15 16:00 ET

24.710
0.0000.00%

Post 16:02 ET

287.59MMarket Cap-6303P/E (TTM)

XOMA Corp Stock Forum

Meltyy

Mar 20 23:18

Biotech Stock News 3/20

$Annovis Bio(ANVS.US)$ 22% Ph2/3 data reporting update
$Taysha Gene Therapies(TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals(TFFP.US)$ 14% Clinical programs update
$Jaguar Health(JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin(SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems(DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences(SLS.US)$ 0% Closes $20M offering & private placement
$Immunic(IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics(NRIX.US)$ 0...

Meltyy

Jan 12 23:27

Biotech Stock News 01/12 @ Open 🛎️📰
$Dyne Therapeutics(DYN.US)$ 4% Closing of public offering
$Geron(GERN.US)$ 4% Participate @ B. Riley Sec. Conf. '24
$ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS(ZEAL.US)$ 2% Capital increase
$XOMA Corp(XOMA.US)$ 1% Arimoclomol NDA filing accepted
$Cellectar BioSciences(CLRB.US)$ 1% Topline results @ conf. call
$CytomX(CTMX.US)$ 0% Present @ B. Riley Sec. Conf. '24

Moomoo AI

Jan 12 05:12

The FDA's acceptance of the NDA is a positive step for XOMA, triggering a milestone payment and bringing the drug closer to potential approval and commercialization. This could lead to future milestone and royalty payments for XOMA, depending on arimoclomol's commercial success.

Press Release: FDA Acceptance of Zevra's Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx

chgocal123

Jul 1, 2022 04:24

$XOMA Corp(XOMA.US)$ can't complain

XOMA Corp(XOMA) 22.280 +8.95%

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall